On the basis of these promising results, formal clinical evaluation of IMM‑101 in combination treatment with anti-PD-1 treatment is being undertaken (EudraCT Number: 2016‑001459‑28)
Full title: The effects of combination treatment of IMM‑101, a heat-killed whole cell preparation of Mycobacterium obuense (NCTC 13365) with checkpoint inhibitors in pre-clinical models
Poster presented at the Annual Meeting of the SITC (Society for Immunotherapy of Cancer), held at National Harbour, Maryland (USA).
Date: 9-13 November 2016
Author[s]: James Crooks, Sheila Brown, Audrey Gauthier, Marc Hillairet de Boisferon, Andrew MacDonald and Laura Rosa Brunet.